Acitretin-Loaded Glycerosomal Cream: Physicochemical Characterization and Antibacterial Evaluation
International Journal of Innovative Science and Research Technology · 29.10.2026 · 11 (10) · 2185
DOI: 10.38124/ijisrt/26oct945 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 29.10.2026. Verfasst von Sumit Daharwal und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
The present study was undertaken with the aim of developing and evaluating a glycerosomal cream formulation containing Acitretin for topical drug delivery. Acitretin is a second-generation retinoid used in the treatment of psoriasis and other keratinization disorders. Due to its poor aqueous solubility and lipophilic nature, glycerosomal vesicular technology was explored to improve its topical delivery. Initially, preformulation studies of Acitretin were carried out to determine its physicochemical properties. Acitretin was found to be a yellow to pale yellow, odorless crystalline powder, freely soluble in ethanol, methanol and DMSO, with a pH of 5.7 and melting point of 228°C.
Zitieren
APA
Daharwal, S., Sahu, A., & Nayak, S. (2026). Acitretin-Loaded Glycerosomal Cream: Physicochemical Characterization and Antibacterial Evaluation. International Journal of Innovative Science and Research Technology, 11(10), 2185. https://doi.org/10.38124/ijisrt/26oct945
Vancouver
Daharwal S, Sahu A, Nayak S. Acitretin-Loaded Glycerosomal Cream: Physicochemical Characterization and Antibacterial Evaluation. International Journal of Innovative Science and Research Technology. 2026;11(10):2185. doi:10.38124/ijisrt/26oct945
BibTeX
@article{Daharwal2026,
author = {Daharwal, Sumit and Sahu, Amit and Nayak, S.},
title = {Acitretin-Loaded Glycerosomal Cream: Physicochemical Characterization and Antibacterial Evaluation},
journal = {International Journal of Innovative Science and Research Technology},
year = {2026},
volume = {11},
number = {10},
pages = {2185},
doi = {10.38124/ijisrt/26oct945}
}
EUVIMED